(1S,3S)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester | 380895-62-5

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 哈马拉生物碱
• 英文名称: (1S,3S)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester
• 英文别名: cis-1-(4-methoxy-phenyl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylic acid methyl ester；methyl (1S,3S)-1-(4-methoxyphenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate；cis-methyl 1-(p-methoxyphenyl)-1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole-3-carboxylate；cis-1-(4-methoxyphenyl)-3-methoxycarbonyl-1,2,3,4-tetrahydro-β-carboline
• CAS: 380895-62-5
• 化学式: C₂₀H₂₀N₂O₃
• 分子量: 336.39
• InChiKey: YCCPHMBIMIJBPW-ROUUACIJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  63.4
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  (1S,3S)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester 在 trialkylamine 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 6.0h， 生成 (6S,12aS)-2-(2-(1-benzylpiperidin-4-yl)ethyl)-6-(4-methoxyphenyl)-2,3,6,7,12,12a-hexahydropyrazino[1′,2′:1,6]pyrido[3,4-b]indole-1,4-dione
  参考文献：
  名称：

  Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5)

  摘要：

  On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compound 2 has proven this method was feasible in AD mouse models. In this study, our work focused on exploring alternative novel tadalafil derivatives (3a-s). Among the 19 analogues, compound 3c exhibited good selective dual-target AChE/PDE5 inhibition and good blood-brain barrier (BBB) permeability. Moreover, its citrate (3c center dot Cit) possessed improved water solubility and good effects against scopolamine-induced cognitive impairment with inhibition of cortical AChE activities and enhancement of cAMP response element-binding protein (CREB) phosphorylation ex vivo.

  DOI：

  10.1021/acschemneuro.8b00014
• 作为产物：
  描述：

  L-色氨酸甲酯盐酸盐 、 4-甲氧基苯甲醛 以 异丙醇 为溶剂， 以30 %的产率得到(1S,3S)-1-(4-methoxyphenyl)-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid methyl ester
  参考文献：
  名称：

  四氢-β-咔啉衍生物作为有效的组蛋白脱乙酰酶 6 抑制剂，具有广谱抗增殖活性

  摘要：

  应用支架跳跃策略合理设计并合成了一系列基于四氢β-咔啉（TH β C）的异羟肟酸作为新型选择性HDAC6抑制剂（sHDAC6is）。几种 TH β C 类似物对 HDAC6 酶具有高效能（IC 50 < 5 nM）和选择性，并对人多发性骨髓瘤(MM) 细胞表现出良好的抗增殖活性。分子对接解释了结构活性关系（SAR）。使用 WB 测定在 RPMI-8226 细胞中证实了 HDAC6 的靶标参与。体外，(1 S , 3 R )-1-(4-氯苯基) -N -(4-(羟基氨基甲酰基)苄基)-2,3,4,9-四氢-1H-吡啶并[3, 4- b ] indole-3-carboxamide ( 14g ) 对各种肿瘤（包括白血病、结肠癌、黑色素瘤和乳腺癌细胞系）表现出有效、广泛的抗增殖活性，优于 ACY-1215。此外， 14g在小鼠口服给药中也表现出良好的药代动力学特性。

  DOI：

  10.1016/j.ejmech.2023.115776

文献信息

• Synthesis of 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-β-carbolines as a new class of antimalarial agents
  作者：Leena Gupta、Kumkum Srivastava、Shubhra Singh、S.K. Puri、Prem M.S. Chauhan

  DOI：10.1016/j.bmcl.2008.04.030

  日期：2008.6

  A series of hybrid molecules 2-[3-(7-Chloro-quinolin-4-ylamino)-alkyl]-1-(substituted phenyl)-2,3,4,9-tetrahydro-1H-beta-carbolines have been synthesized and screened for their in vitro antimalarial activity against chloroquine-sensitive strains of Plasmodium falciparum. Compounds 26, 32, and 34 have shown MIC in the range of 0.05-0.11 microM and are in vitro several folds more active than chloroquine

  合成了一系列杂化分子2- [3-（7-氯喹啉-4-基氨基）-烷基] -1-（取代的苯基）-2,3,4,9-四氢-1H-β-咔啉并筛选了它们对恶性疟原虫氯喹敏感菌株的体外抗疟活性。化合物26、32和34的MIC在0.05-0.11 microM的范围内，并且在体外具有比氯喹高几倍的活性。
• [EN] COMPOUNDS FOR TREATMENT OF METABOLIC SYNDROME<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DU SYNDROME MÉTABOLIQUE
  申请人：SJT MOLECULAR RES S L

  公开号：WO2012130912A1

  公开（公告）日：2012-10-04

  Present invention refers to new compounds of formula I or II, its synthesis and its use in the treatment of metabolic syndrome, particularly for the treatment of type I or type II diabetes and/or metabolic syndrome or metabolic disease or metabolic disorders.

  本发明涉及公式I或II的新化合物，其合成以及在治疗代谢综合征中的应用，特别是用于治疗I型或II型糖尿病和/或代谢综合征或代谢疾病或代谢紊乱。
• Simple and efficient synthesis of tetrahydro-β-carbolines via the Pictet–Spengler reaction in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP)
  作者：Li-Na Wang、Su-Li Shen、Jin Qu

  DOI：10.1039/c4ra03628j

  日期：——

  1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) can act as both the solvent and the catalyst to effectively promote the Pictet–Spengler reaction.

  1,1,1,3,3,3-六氟-2-丙醇（HFIP）可以作为溶剂和催化剂，有效地促进Pictet-Spengler反应。
• Synthesis and cytotoxicity evaluation of (tetrahydro-β-carboline)-1,3,5-triazine hybrids as anticancer agents
  作者：Ravi Kumar、Leena Gupta、Pooja Pal、Shahnawaz Khan、Neetu Singh、Sanjay Babu Katiyar、Sanjeev Meena、Jayanta Sarkar、Sudhir Sinha、Jitendra Kumar Kanaujiya、Savita Lochab、Arun Kumar Trivedi、Prem M.S. Chauhan

  DOI：10.1016/j.ejmech.2010.02.001

  日期：2010.6

  A series of tetrahydro-beta-carbolines and 1,3,5-triazine hybrids have been synthesized and evaluated for their cytotoxicity against a panel of eight human cancer cell lines and normal human fibroblasts (NIH3T3). It led us to discovery of racemic compounds 69, 71 and 75, which are selectively cytotoxic towards KB (oral cancer) cell line with IC(50) values of 1058, 664 7 and 122.2 nM, respectively, while their enantiopure forms are less active and not selective. Enantiopure compound 42 showed 2 5 times more selectivity towards MCF7 cells over normal fibroblast NIH3T3 cells with an IC(50) value of 740 nM, also arrests cell cycle in G(1) phase and induces apoptosis in MCF7 and MDA MB231cell lines.
• Discovery of novel phosphatidylcholine-specific phospholipase C drug-like inhibitors as potential anticancer agents
  作者：Chatchakorn Eurtivong、Lisa I. Pilkington、Michelle van Rensburg、Reuben M. White、Harpreet Kaur Brar、Shaun Rees、Emily K. Paulin、Chris Sun Xu、Nabangshu Sharma、Ivanhoe K.H. Leung、Euphemia Leung、David Barker、Jóhannes Reynisson

  DOI：10.1016/j.ejmech.2019.111919

  日期：2020.2

  Phosphatidylcholine-specific phospholipase C (PC-PLC) is a promising target for new anticancer treatment. Herein, we report our work in the discovery of novel drug-like PC-PLC inhibitors. Virtual screening led to the identification of promising hits from four different structural series that contain the molecular scaffold of benzenesulphonamides (10), pyrido[3,4-b]indoles (22), morpholinobenzoic acid (84) and benzamidobenzoic acid (80). 164 structural analogues were tested to investigate the chemical space around the hit series and to generate preliminary structurally activity relationships (SAR). Two of the pyrido[3,4-b]indoles (22_10 and 22_15) had comparable or better potency as D609, an established but non-drug-like PC-PLC inhibitor. Furthermore, three morpholinobenzoic acids (84, 84_4 and 84_5) had superior potency than D609. Therefore, this study paves the way towards the development of drug-like PL-PLC inhibitors as potential anticancer agents. (C) 2019 Elsevier Masson SAS. All rights reserved.